Itron (NASDAQ:ITRI) SVP Sells $22,049.20 in Stock

Itron, Inc. (NASDAQ:ITRIGet Free Report) SVP Donald Reeves III sold 277 shares of the company’s stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total value of $22,049.20. Following the completion of the sale, the senior vice president owned 29,674 shares of the company’s stock, valued at $2,362,050.40. This trade represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Stock Performance

Shares of NASDAQ:ITRI traded up $0.93 during midday trading on Thursday, hitting $82.28. The company had a trading volume of 376,875 shares, compared to its average volume of 937,478. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.66 and a quick ratio of 2.24. The company has a market cap of $3.65 billion, a price-to-earnings ratio of 13.15, a PEG ratio of 0.68 and a beta of 1.35. Itron, Inc. has a 12-month low of $77.77 and a 12-month high of $142.00. The company has a fifty day moving average of $88.85 and a two-hundred day moving average of $94.73.

Itron (NASDAQ:ITRIGet Free Report) last posted its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.26 by $0.23. The firm had revenue of $586.98 million during the quarter, compared to analyst estimates of $572.04 million. Itron had a return on equity of 19.54% and a net margin of 12.31%.Itron’s revenue was down 3.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. On average, equities research analysts expect that Itron, Inc. will post 6.01 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ITRI. Guggenheim set a $155.00 price objective on Itron in a research note on Friday, February 13th. Weiss Ratings restated a “hold (c)” rating on shares of Itron in a research note on Friday, May 8th. Robert W. Baird set a $128.00 price target on Itron and gave the stock an “outperform” rating in a research note on Wednesday, February 18th. Zacks Research upgraded Itron from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 26th. Finally, TD Cowen cut their price target on Itron from $145.00 to $130.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Eight research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $131.22.

View Our Latest Stock Report on Itron

Institutional Investors Weigh In On Itron

A number of institutional investors have recently bought and sold shares of the business. California State Teachers Retirement System increased its stake in Itron by 28.3% in the 1st quarter. California State Teachers Retirement System now owns 55,042 shares of the scientific and technical instruments company’s stock worth $4,933,000 after buying an additional 12,154 shares in the last quarter. Entropy Technologies LP increased its stake in Itron by 6.3% in the 1st quarter. Entropy Technologies LP now owns 8,278 shares of the scientific and technical instruments company’s stock worth $742,000 after buying an additional 490 shares in the last quarter. Renaissance Technologies LLC increased its stake in Itron by 10.1% in the 1st quarter. Renaissance Technologies LLC now owns 461,761 shares of the scientific and technical instruments company’s stock worth $41,388,000 after buying an additional 42,300 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its stake in Itron by 12.2% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 673,420 shares of the scientific and technical instruments company’s stock worth $60,359,000 after buying an additional 73,020 shares in the last quarter. Finally, Caxton Associates LLP purchased a new stake in Itron in the 1st quarter worth $2,212,000. Hedge funds and other institutional investors own 96.19% of the company’s stock.

About Itron

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Featured Stories

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.